Citric acid cycle

The citric acid cycle, also known as the Krebs cycle or the tricarboxylic acid (TCA) cycle, is a series of enzyme-catalyzed chemical reactions that constitute the central metabolic hub in all aerobic organisms, responsible for the oxidation of acetyl-CoA derived from carbohydrates, fats, and proteins to produce energy in the form of ATP, and supplying precursors for various biosynthetic pathways.

Overview and Discovery

The citric acid cycle is a cyclic metabolic pathway that takes place in the mitochondrial matrix of eukaryotic cells and in the cytoplasm of prokaryotes. It was first elucidated by the German-British biochemist Hans Adolf Krebs in 1937, for which he received the Nobel Prize in Physiology or Medicine in 1953. The cycle is so named because citrate, the ionized form of citric acid, is the first intermediate formed. It serves as the final common pathway for the oxidation of fuel molecules, where acetyl-CoA, the two-carbon end product of glycolysis, fatty acid β-oxidation, and amino acid catabolism, is completely oxidized to carbon dioxide.

Steps of the Cycle

The cycle comprises eight major steps, each catalyzed by a specific enzyme. The starting point is the condensation of a four-carbon oxaloacetate molecule with a two-carbon acetyl-CoA unit to form the six-carbon citrate. Citrate is then isomerized to isocitrate. Isocitrate undergoes oxidative decarboxylation to produce α-ketoglutarate, releasing one molecule of CO₂ and generating NADH. α-Ketoglutarate is further oxidatively decarboxylated to form succinyl-CoA, releasing another CO₂ and generating a second NADH. Succinyl-CoA is converted to succinate in a substrate-level phosphorylation step that produces GTP (or ATP). Succinate is oxidized to fumarate, reducing FAD to FADH₂. Fumarate is hydrated to malate, and malate is finally oxidized back to oxaloacetate, generating a third NADH. The regenerated oxaloacetate can then combine with another acetyl-CoA to begin the cycle anew.

Energetics and Reducing Equivalents

For each turn of the cycle, one acetyl-CoA is consumed. The direct energy yield from one cycle includes one GTP (or ATP) via substrate-level phosphorylation. The primary energy harvest, however, comes from the high-energy electron carriers generated: three molecules of NADH and one molecule of FADH₂. These reducing equivalents are subsequently oxidized by the electron transport chain in the inner mitochondrial membrane, driving oxidative phosphorylation to produce the majority of the cell's ATP. Complete oxidation of one acetyl-CoA unit via the cycle and subsequent oxidative phosphorylation can yield approximately 10-12 ATP molecules.

Regulation

The citric acid cycle is tightly regulated to match cellular energy demands. Key regulatory enzymes include citrate synthase (the first committed step), isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase complex. These enzymes are allosterically inhibited by ATP and NADH, signaling high energy charge, and activated by ADP and NAD⁺, signaling low energy charge. Calcium ions, which increase during muscle contraction, also stimulate several cycle enzymes. Furthermore, the availability of substrates (acetyl-CoA and oxaloacetate) and the cycle's integration with other pathways are crucial regulatory factors.

Anaplerosis and Cataplerosis

To maintain cycle intermediates at sufficient levels for continuous operation, anaplerotic reactions replenish these intermediates. A major anaplerotic reaction is the carboxylation of pyruvate to oxaloacetate, catalyzed by pyruvate carboxylase. Conversely, cataplerotic reactions drain cycle intermediates for biosynthesis, such as the use of α-ketoglutarate for amino acid synthesis or oxaloacetate for gluconeogenesis. The balance between anaplerosis and cataplerosis is vital for metabolic homeostasis.

Role in Biosynthesis

Beyond its catabolic role, the citric acid cycle is a critical source of precursors for anabolism. Intermediates are siphoned off for the synthesis of various molecules: oxaloacetate and α-ketoglutarate for amino acids; succinyl-CoA for heme synthesis; citrate for fatty acid and cholesterol synthesis; and oxaloacetate for glucose synthesis via gluconeogenesis. This dual catabolic and anabolic nature designates the cycle as an amphibolic pathway.

Clinical and Biotechnological Significance

Defects in enzymes of the citric acid cycle are rare but can lead to severe metabolic disorders, often affecting tissues with high energy demands like the brain and muscles. Understanding the cycle is fundamental in fields like biochemistry, nutrition, and medicine. In biotechnology, manipulating cycle fluxes is a target for metabolic engineering to improve the yield of desired compounds in microorganisms or to understand diseases like cancer, where cancer cells often exhibit altered cycle activity to support rapid proliferation.